Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients

Wulf H. Utian, Kenneth A. Burry, David F. Archer, John Christopher G. Gallagher, Robert L. Boyett, Martine P. Guy, Gilles J. Tachon, Harbajan K. Chadha-Boreham, Agnès A. Bouvet

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to evaluate the efficacy and safety of 3 dosages of Esclim, delivering 0.025 mg, 0.050 mg, or 0.100 mg 17β-estradiol per 24 hours, in the treatment of moderate to severe vasomotor symptoms. STUDY DESIGN: In this double-blind, placebo-controlled, parallel-group, multicenter trial, 196 highly symptomatic menopausal women received 12 weeks of continuous unopposed treatment with 1 of the 3 dosages of Esclim or a matching placebo patch. RESULTS: The reduction in frequency of moderate to severe vasomotor symptoms was statistically significant compared with placebo (P

Original languageEnglish
Pages (from-to)71-79
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume181
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Estradiol
Placebos
Safety
Multicenter Studies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. / Utian, Wulf H.; Burry, Kenneth A.; Archer, David F.; Gallagher, John Christopher G.; Boyett, Robert L.; Guy, Martine P.; Tachon, Gilles J.; Chadha-Boreham, Harbajan K.; Bouvet, Agnès A.

In: American Journal of Obstetrics and Gynecology, Vol. 181, No. 1, 1999, p. 71-79.

Research output: Contribution to journalArticle

Utian, Wulf H. ; Burry, Kenneth A. ; Archer, David F. ; Gallagher, John Christopher G. ; Boyett, Robert L. ; Guy, Martine P. ; Tachon, Gilles J. ; Chadha-Boreham, Harbajan K. ; Bouvet, Agnès A. / Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. In: American Journal of Obstetrics and Gynecology. 1999 ; Vol. 181, No. 1. pp. 71-79.
@article{7d76cb73c88c46aab7dc74cf1a053017,
title = "Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients",
abstract = "OBJECTIVE: Our purpose was to evaluate the efficacy and safety of 3 dosages of Esclim, delivering 0.025 mg, 0.050 mg, or 0.100 mg 17β-estradiol per 24 hours, in the treatment of moderate to severe vasomotor symptoms. STUDY DESIGN: In this double-blind, placebo-controlled, parallel-group, multicenter trial, 196 highly symptomatic menopausal women received 12 weeks of continuous unopposed treatment with 1 of the 3 dosages of Esclim or a matching placebo patch. RESULTS: The reduction in frequency of moderate to severe vasomotor symptoms was statistically significant compared with placebo (P",
author = "Utian, {Wulf H.} and Burry, {Kenneth A.} and Archer, {David F.} and Gallagher, {John Christopher G.} and Boyett, {Robert L.} and Guy, {Martine P.} and Tachon, {Gilles J.} and Chadha-Boreham, {Harbajan K.} and Bouvet, {Agn{\`e}s A.}",
year = "1999",
doi = "10.1016/S0002-9378(99)70438-2",
language = "English",
volume = "181",
pages = "71--79",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients

AU - Utian, Wulf H.

AU - Burry, Kenneth A.

AU - Archer, David F.

AU - Gallagher, John Christopher G.

AU - Boyett, Robert L.

AU - Guy, Martine P.

AU - Tachon, Gilles J.

AU - Chadha-Boreham, Harbajan K.

AU - Bouvet, Agnès A.

PY - 1999

Y1 - 1999

N2 - OBJECTIVE: Our purpose was to evaluate the efficacy and safety of 3 dosages of Esclim, delivering 0.025 mg, 0.050 mg, or 0.100 mg 17β-estradiol per 24 hours, in the treatment of moderate to severe vasomotor symptoms. STUDY DESIGN: In this double-blind, placebo-controlled, parallel-group, multicenter trial, 196 highly symptomatic menopausal women received 12 weeks of continuous unopposed treatment with 1 of the 3 dosages of Esclim or a matching placebo patch. RESULTS: The reduction in frequency of moderate to severe vasomotor symptoms was statistically significant compared with placebo (P

AB - OBJECTIVE: Our purpose was to evaluate the efficacy and safety of 3 dosages of Esclim, delivering 0.025 mg, 0.050 mg, or 0.100 mg 17β-estradiol per 24 hours, in the treatment of moderate to severe vasomotor symptoms. STUDY DESIGN: In this double-blind, placebo-controlled, parallel-group, multicenter trial, 196 highly symptomatic menopausal women received 12 weeks of continuous unopposed treatment with 1 of the 3 dosages of Esclim or a matching placebo patch. RESULTS: The reduction in frequency of moderate to severe vasomotor symptoms was statistically significant compared with placebo (P

UR - http://www.scopus.com/inward/record.url?scp=0003026989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0003026989&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(99)70438-2

DO - 10.1016/S0002-9378(99)70438-2

M3 - Article

VL - 181

SP - 71

EP - 79

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -